GU Cast | Urology Podcast

Today we are joined by Nurse Consultants, Emma Birch and Marc Diocera, and also by patient advocate Alan White, to discuss how they work together to prepare patients and their loved ones who are coming up to robotic prostatectomy. They describe the evolution of their "Robocare" program over teh past ten years, and look ahead to how COVID19 is creating opportunities to make it even more a...

Today we hook up with our good friends at Urotoday.com. Dr Alicia Morgans interviews Professor Declan Murphy for the Urotoday.com website, and we are cross-posting as a GU Cast podcast, introduced by Dr Renu Eapen. Alicia interviews Declan about the COVID situation in Australia as part of the Urotoday.com global overview. 

Dr Matt Cooperberg from UCSF joins us on GU Cast to give us his Top 5 "Good Things to Come Out of COVID". The usual mixture of banter and bonhomie with Declan Murphy and Renu Eapen from Peter MacCallum Cancer Centre. Enjoy!!

Today we are joined by three giants in the world of stereotactic-assisted body radiotherapy (SBRT), to discuss the use of SBRT in various stages of prostate cancer. Associate Professor Shankar Siva from Peter MacCallum Cancer Centre joins us in the studio, along with Dr Alison Tree from the Royal Marsden in London, and Dr Piet Ost from Ghent. Your usual hosts are Professor Declan Murphy and Dr Ren...

Nurses are stepping up to support cancer patients during the COVID pandemic. Today we hear from Liz Medhurst, Urology Nurse Consultant at Peter MacCallum Cancer Centre in Melbourne, in discussion with Louisa Fleure, Lead GU Oncology Clinical Nurse Specialist at Guy's & St Thomas' NHS Foundation Trust in London. Louisa and Liz discuss some of teh innovative ways we can support cancer...

A hope-filled podcast to bring some sunshine to your day. GU Cast chats to Dr Maria Ribal in Barcelona, and Dr Stacy Loeb in New York. Lots of cheery chat to brighten up your day!

Today we are joined by Dr Rob Hamilton, Urologist at Princess Margaret Hospital in Toronto, and world-leading testis cancer specialist. Rob has been running a randomised trial of telehealth surveillance for testis cancer patients so has some great insights and advice for the rest of us. We also discuss his interest in testis cancer biomarkers and robotic surgery for retroperitoneal testicular canc...

Thanks to Dr Howard Soule and our friends at the Prostate Cancer Foundation in the USA, we are delighted to post this GU Cast special episode on PSMA PET/CT. PCF today hosted their first PCF Global Journal Club Webinar, focussing on PSMA PET/CT. Professor Michael Hofman presented an overview of the proPSMA trial recently published in the Lancet, with a lively panel discussion and questions from th...

Dr SIma Porten, Urologist at the University of California San Francisco, joins GU Cast to discuss the management of bladder cancer during the COVID pandemic. Huge challenges balancing risks of treatment vs risks of disease progression.  Regular hosts Declan Murphy and Renu Eapen are joined by Dr Ben Tran, medical oncologist at Peter MacCallum Cancer Centre, Melbourne 

Dr Ben Challacombe, Urologist at Guy's & St Thomas' NHS Foundation Trust, & Chair of BAUS Oncology, joins us on GU Cast to discuss life in London as COVID nears its peak. Ben and the BAUS Oncology Committee released guidelines on the management of renal cancer a few days ago and he joins Declan Murphy, Renu Eapen, and Daniel Moon to discuss these. 

Professor Alberto Briganti from San Raffaele University in Milan joins us for this episode of GU Chat. Today we focus on the challenges of managing localised prostate cancer during the COVID crisis. Amazing perspectives from the North of Italy. Regular hosts Declan Murphy and Renu Eapen are also joined this week by Dr Daniel Moon, Urologist at Peter MacCallum Cancer Centre. 

Professor Declan Murphy and Dr Renu Eapen host the launch episode of GU Cast , a podcast focussing on GU cancers, from the team at Peter MacCallum Cancer Centre in Melbourne. Today our guest is Professor Michael Hofman, who discusses the proPSMA trial, published in The Lancet the week. Professor Caroline Moore from University College London joins us to comment.